Scottish Science Advisory Council

Appointment of Dr. David John Jeans CBE as HistoIndex's Non-Executive Chairman

Retrieved on: 
Tuesday, January 10, 2023
Fibrosis, Cancer, Health, Trustee, Drug development, Non-executive director, Cardiff University, Johnson & Johnson, CBE, Growth, Bristol Myers Squibb, Health care, Scottish Science Advisory Council, Army Science Board, Digital health, Francis Crick Institute, Commander, Management, Science

Since the incorporation of the Company, Mr Sim Giok Lak has guided HistoIndex with his wealth of industrial and corporate experiences.

Key Points: 
  • Since the incorporation of the Company, Mr Sim Giok Lak has guided HistoIndex with his wealth of industrial and corporate experiences.
  • Dr. David John Jeans was first appointed to the Board as a non-executive director on 17th May 2022.
  • In 2012, John was awarded the Commander of the Order of the British Empire (CBE) for his significant contributions to Life Sciences, Healthcare and Science.
  • Says John, ''I am excited to be appointed as the Non-Executive Chairman of the Board.

Appointment of Dr. David John Jeans CBE as HistoIndex's Non-Executive Chairman

Retrieved on: 
Tuesday, January 10, 2023
Fibrosis, Cancer, Health, Trustee, Drug development, Non-executive director, Cardiff University, Johnson & Johnson, CBE, Growth, Bristol Myers Squibb, Health care, Scottish Science Advisory Council, Army Science Board, Digital health, Francis Crick Institute, Commander, Management, Science

Since the incorporation of the Company, Mr Sim Giok Lak has guided HistoIndex with his wealth of industrial and corporate experiences.

Key Points: 
  • Since the incorporation of the Company, Mr Sim Giok Lak has guided HistoIndex with his wealth of industrial and corporate experiences.
  • Dr. David John Jeans was first appointed to the Board as a non-executive director on 17th May 2022.
  • In 2012, John was awarded the Commander of the Order of the British Empire (CBE) for his significant contributions to Life Sciences, Healthcare and Science.
  • Says John, ''I am excited to be appointed as the Non-Executive Chairman of the Board.

HistoIndex Welcomes Life Sciences and MedTech Visionary, David John Jeans CBE, to Board of Directors

Retrieved on: 
Wednesday, May 18, 2022
Photon, Cancer, Cardiff University, A*STAR, Francis Crick Institute, NASH, PMO, Agency for Science, Technology and Research, Scottish Science Advisory Council, Agency, Director, Multimedia, Patient, Medical Research Council, Prime Minister's Office (India), Commander, Health, General of the branch, List of life sciences, Bristol Myers Squibb, Health care, Medical Research Council (United Kingdom), Non-alcoholic fatty liver disease, Artificial intelligence, Technology, Algorithm, Johnson & Johnson, FDA, CBE, Cros, Smith & Nephew, Board, Public Service Medal, Digital health, Drug development, Adoption, GE Healthcare, TPE, Trustee, Drug discovery, SHG, Medical device, Pharmaceutical industry, Research, Science

John brings with him a global and diverse experience in life sciences, along with a deep interest in healthcare technologies to improve clinical standards and care for patients.

Key Points: 
  • John brings with him a global and diverse experience in life sciences, along with a deep interest in healthcare technologies to improve clinical standards and care for patients.
  • John will provide guidance to the senior management at HistoIndex to transform histopathological standards in diagnostics and drug development with the global adoption of stain-free AI digital pathology for fibrotic diseases.
  • In 2012, John was awarded the Commander of the Order of the British Empire (CBE) for his significant contributions to Life Sciences, Healthcare and Science.
  • Says Dr. Gideon Ho, Chief Executive Officer of HistoIndex, "All of us at HistoIndex are very delighted to welcome Dr. John Jeans, a renowned thought leader and visionary in the life sciences space.

HistoIndex Welcomes Life Sciences and MedTech Visionary, David John Jeans CBE, to Board of Directors

Retrieved on: 
Wednesday, May 18, 2022
Photon, Cancer, Cardiff University, A*STAR, Francis Crick Institute, NASH, PMO, Agency for Science, Technology and Research, Scottish Science Advisory Council, Agency, Director, Patient, Medical Research Council, Prime Minister's Office (India), Commander, Health, General of the branch, List of life sciences, Bristol Myers Squibb, Health care, Medical Research Council (United Kingdom), Non-alcoholic fatty liver disease, Artificial intelligence, Technology, Algorithm, Johnson & Johnson, FDA, CBE, Cros, Smith & Nephew, Board, Public Service Medal, Digital health, Drug development, Adoption, GE Healthcare, TPE, Trustee, Drug discovery, SHG, Medical device, Pharmaceutical industry, Research, Science

John brings with him a global and diverse experience in life sciences, along with a deep interest in healthcare technologies to improve clinical standards and care for patients.

Key Points: 
  • John brings with him a global and diverse experience in life sciences, along with a deep interest in healthcare technologies to improve clinical standards and care for patients.
  • John will provide guidance to the senior management at HistoIndex to transform histopathological standards in diagnostics and drug development with the global adoption of stain-free AI digital pathology for fibrotic diseases.
  • In 2012, John was awarded the Commander of the Order of the British Empire (CBE) for his significant contributions to Life Sciences, Healthcare and Science.
  • Says Dr. Gideon Ho, Chief Executive Officer of HistoIndex, "All of us at HistoIndex are very delighted to welcome Dr. John Jeans, a renowned thought leader and visionary in the life sciences space.